Maryland Qualifying Conditions: Detailed Guide
About the Qualifying Medical Conditions
Below is information about each qualifying condition and the research that informed Maryland's decision to include it in the state program.
Cancer, Cachexia/Wasting Syndrome, Anorexia, Severe Nausea
These are approved qualifying conditions under Maryland's medical cannabis program. Maryland included these conditions based on research examining cannabinoid use among cancer patients experiencing treatment-related symptoms.
Severe or Chronic Pain
Chronic pain is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on systematic reviews examining cannabinoid use among patients with chronic pain conditions.
Seizures (Epilepsy)
Seizure disorders, including epilepsy, are approved qualifying conditions under Maryland's medical cannabis program. Maryland included these conditions based on clinical trial research examining CBD in patients with treatment-resistant epilepsy.
Severe or Persistent Muscle Spasms, Multiple Sclerosis (MS)
Muscle spasms and MS are approved qualifying conditions under Maryland's medical cannabis program. Maryland included these conditions based on clinical research examining cannabinoid use in patients with MS-related spasticity.
Glaucoma
Glaucoma is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on early research examining the relationship between cannabinoids and intraocular pressure.
PTSD
PTSD is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on research examining cannabinoid use among patients with PTSD.
Parkinson's Disease
Parkinson's Disease is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on research examining cannabinoid use among Parkinson's patients.
Crohn's Disease
Crohn's Disease is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on clinical research examining cannabis use in patients with Crohn's Disease.
Hepatitis C
Hepatitis C is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on research examining cannabis use among patients undergoing antiviral treatment.
HIV/AIDS
HIV/AIDS is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on research examining cannabinoid use among HIV/AIDS patients.
ALS
ALS is an approved qualifying condition under Maryland's medical cannabis program. Maryland included this condition based on research surveying ALS patients about symptom management.
Terminal Illness
Terminal illness is an approved qualifying condition under Maryland's medical cannabis program as determined by the Maryland Medical Cannabis Commission.
Petition Process for Adding New Conditions
- How to Petition: Maryland residents may petition the Maryland Medical Cannabis Commission (MMCC) to include additional medical conditions. Petitions must include medical evidence, scientific research, and endorsements from healthcare professionals.
- Review Timeline: Petitions are typically decided within approximately 180 days.
Medical Disclaimer
This page provides information about Maryland's qualifying conditions for medical cannabis. The inclusion of a condition in Maryland's program does not constitute medical advice or a guarantee of therapeutic benefit. Individual results vary. Potential side effects may include dizziness, sedation, and cognitive changes. Always consult a healthcare provider before starting treatment.